Back to search

Article

Differential impact of six JAK inhibitors on myeloid cell differentiation and T cell stimulatory capacity: An in vitro comparative study

2026-04-16

Abstract excerpt

<title>Abstract</title> <p>Janus kinase inhibitors (JAKis) modulate immune signaling, yet their effects on myeloid lineages and T-cell responses remain incompletely defined. We systematically compared six JAKis—tofacitinib, baricitinib, peficitinib, upadacitinib, filgotinib, and deucravacitinib—in a GM-CSF/IL-4 bone-marrow culture system. Flow cytometry quantified myeloid-derived suppressor cells (MDSCs) and dend...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0e90fb8f-1844-5c86-90bd-efdd7fa7b3bd
DOI
10.21203/rs.3.rs-7882005/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Differential impact of six JAK inhibitors on myeloid cell differentiation and T cell stimulatory capacity: An in vitro comparative studyDOI 10.21203/rs.3.rs-7882005/v1
Select a neighboring publication to make it the new centre.